Safety and Efficacy of BAY1192631 in Japanese Patients With Methicillin-resistant Staphylococcus Aureus (MRSA) Infections

NCT01967225 PHASE3 COMPLETED Results posted

The aim of this study is to see the efficacy and safety of BAY1192631 in Japanese patients with methicillin-resistant staphylococcus aureus (MRSA) (skin and soft tissue infections (SSTI) and SSTI-related bacteremia).

Details

Lead sponsor	Bayer
Phase	PHASE3
Status	COMPLETED
Enrolment	125
Start date	Sat Nov 23 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Fri Oct 28 2016 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Skin Diseases, Infectious

Interventions

• Tedizolid Phosphate (Sivextro, BAY1192631)
• Linezolid

Countries

Japan